Anaphylaxis

Food Allergy

Seasonal Allergy

Allergy

Biosimilars

Arrhythmia

Atherosclerotic Cardiovascular Disease

Cardiomyopathy

Dyslipidemia

Heart Failure

Hypertension

Stroke

Structural Heart Disease

Venous Thromboembolism

Cardiology

Acne

Alopecia

Atopic Dermatitis

Chronic Idiopathic Urticaria

Hidradenitis Suppurativa

Plaque Psoriasis

Rosacea

Vitiligo

Dermatology

Hormonal Disorders

Polycystic Ovary Syndrome

Thyroid Disorders

Type 1 Diabetes

Type 2 Diabetes

Endocrinology

FDA News

COVID-19

Influenza

Vaccination

Family Medicine

C Difficile Infection

Gastroesophageal Reflux Disease (GERD)

Inflammatory Bowel Disease

Irritable Bowel Syndrome

Peptic Ulcer

Ulcerative Colitis

Gastroenterology

Alzheimer Disease

Parkinson Disease

Geriatrics

Anemia

Sickle Cell

Hematology

Alpha-1 antitrypsin deficiency

Cholangitis

Hepatitis C

MASH / MASLD

Hepatology

Hospital Medicine

HIV/AIDS

Infectious Disease

Internal Medicine

Chronic Kidney Disease

IgA Nephropathy

Nephrology

Epilepsy

Migraine

Tardive Dyskinesia

Traumatic Brain Injury

Neurology

Obesity Management

Age-Related Macular Degeneration

Diabetic Macular Edema

Geographic Atrophy

Uveitis

Ophthalmology

Acute Pain

Chronic Pain

Multiple Sclerosis

Neuropathic Pain

Pain

Pediatrics

ADHD

Addiction

Bipolar Disorder

Major Depressive Disorder

PTSD

Schizophrenia

Psychiatry

Asthma

COPD

Lung Cancer

Pulmonary Fibrosis

Pulmonology

Amyloidosis

Huntington Disease

Lysosomal Storage Disorders

Vasculitis

RDR Alert®

Fibromyalgia

Gout

Lupus

Osteoarthritis

Osteoporosis

Psoriatic Arthritis

Rheumatoid Arthritis

Spondyloarthritis

Rheumatology

Insomnia

Obstructive Sleep Apnea

Sleep

Plastic surgery

Surgery

Women's Health

News

Media

Podcasts

Shows

State Of Sciences - Presentations

Videos

Webinars

Multimedia Series

CURE Connections®

Insights

Medcast

News Network

Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

Partners

CME/CE

Resources

Digital Supplements

Interactive Tools

Live Events

Press Release

Publications

Advisory Board

Subscribe

Tim Smith joined the MJH Life Sciences team as an assistant editor for HCPLive in August 2022. He graduated from UC Berkeley with a degree in political science, working in multimedia journalism as a staff writer prior to joining MJH. In his spare time, he enjoys reading, watching TV, listening to podcasts, and rock climbing. You can contact him at 

This month’s Lungcast features a discussion on pulmonary function tests and the controversial practice of using race-based normal values.

Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD

Abigail Brooks is an assistant editor for 

She joined MJH Life Sciences in August 2023 shortly after graduating from Monmouth University where she earned her BA in Communication with a concentration in Public Relations/Journalism and later an MA in Interactive Digital Media. She enjoys traveling, running, and reading books. She can be reached at abrooks@mjhlifesciences.com.

Articles

Preliminary topline week 96 results showed statistically significant reversal of MASH compensated cirrhosis with efruxifermin in complete and ITT analyses.

Efruxifermin Reverses MASH Compensated Cirrhosis in Phase 2b SYMMETRY Study

Greater levels of physical activity and higher diet quality were linked to a reduced risk of MASLD, MetALD, and compensated advanced chronic liver disease.

High-Quality Diet, Physical Activity Could Help Reduce MASLD and MetALD Risk

Victoria Johnson joined the MJH Life Sciences in 2020 and has written for NeurologyLive, CGTLive, and now HCPLive. You can reach her at vjohnson@mjhlifesciences.com

New research highlights the importance of immunomodulation before pegloticase exposure.

Pegloticase + MTX for Gout Not Effective After Pegloticase Monotherapy

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

About Us

Advertise

Editorial

Contact Us

Do Not Sell My Information

Privacy

Terms & Conditions

HCPLive - Clinical news for connected physicians

Facebook

LinkedIn

Spotlight

The Respiratory Report

DME & nAMD On-Demand Presentation

Clinical

Arterial Disease

Diabetes

Geriatric Medicine

Video Series

Post Conference Perspectives

clinical page is a resource for content on every specialty, disease, and topic available on our medical news site.

Clinical Topics

Mora and Sadreameli join Lungcast to provide a back-to-school health blueprint, including topics like rescue inhalers, vaccination, vaping and air quality.

Prepare Your Lungs for Back-to-School with Juanita Mora, MD & S. Christy Sadreameli, MD

Back-to-school season is officially upon the US, as 

 are gradually subsiding and giving way to the mid-August tradition of fall clothes shopping, classroom orientations and the return of routine for students.

Perhaps understated in the annual preparation stage for the first September school bell is the tradition of health planning for many at-risk children. At a time when pediatric allergy and asthma rates are continually rising, there’s plenty of conference between caregivers, pediatricians and school nurses regarding rescue medication, as well as how to avoid seasonal and environmental risks for children this school year.

Asthma and allergic triggers are only scratching the surface of what should be discussed with caregivers leading into the school year, though.

For the August 2024 episode of Lungcast, a pair of allergic and pulmonary disease experts join to provide a blueprint of back-to-school health strategies for children and their parents. Juanita Mora, MD, physician and chief executive officer of the Chicago Allergy Center, and S. Christy Sadreameli, assistant professor of pediatrics at Johns Hopkins University School of Medicine, review asthma, vaping, vaccines and more.

Throughout their half-hour conversation, Mora and Sadreameli touch on strategic conversations surrounding pediatric asthma control, immunization updates and collaborative care with school nurses. The duo also delve into trends in pediatric health that may affect classrooms, including Asthma Peak Week, poor indoor air quality, and the e-cigarette epidemic among young Americans.

Lungcast is a monthly respiratory news podcast series hosted by Albert Rizzo, MD, chief medical officer of the ALA, and produced by HCPLive.

Back-to-School Asthma and Lung Health with Juanita Mora, MD and S. Christy Sadreameli, MD

A new study showed that experiencing worsened allergic rhinitis symptoms in air-conditioned environments may predict disease severity.

Poor Allergic Rhinitis Symptoms in Air Conditioning May Predict Greater Severity

David B. Peden, MD

Elizabeth Cerceo, MD

Lewis Ziska, PhD

Every few years scientists re-confirm, through new research, that airborne pollen has substantial respiratory health impacts and that anthropogenic or man-made climate change is known to exacerbate these impacts by increasing concentrations of pollen and extending pollen seasons.

Studies conducted in both greenhouse and field settings have shown a link between pollen levels and rising temperatures, indicating a need for public health policies and awareness raising regarding anthropogenic climate change's role in pollen seasons.

 Such a shift in the environment is uniquely foreboding as it has been suggested that it can adversely affect human health by contributing to rises in 

 editorial team regularly interviews experts in the medical field with the aim of raising awareness of various health concerns and informing clinicians on such topics. This feature article represents a deep dive into the subject of climate change in honor of Earth Day, specifically in its adverse relationship to allergic disease.

In this video series, 3 experts were featured to discuss such issues and to highlight research on the causative relationship linking air pollution, rising temperatures, and prevalence of different allergic conditions.

The team spoke with David B. Peden, MD, the Harry S. Andrews professor of pediatrics, medicine and microbiology/immunology and associate director of the Center for Environmental Medicine, Asthma & Lung Biology at the University of North Carolina (UNC) School of Medicine. We also interviewed Elizabeth Cerceo, MD, associate internal medicine program director and the director of environmental health in the division of hospital medicine at Cooper University Health Care.

Lastly, we spoke with Lewis Ziska, PhD, an associate professor of environmental health sciences at the Mailman School of Public Health at Columbia University and the Climate and Health Certificate Lead. Ziska, Peden, and Cerceo each are leading experts in their fields and have contributed their views and research on this topic throughout their careers.

Given the surge of interest around the dangers of anthropogenic climate change and the rising incidence of allergic diseases in industrialized countries, these 3 interviews posted above highlight several key topics regarding new research, public health needs, and changing perceptions regarding humanity’s shared impact on the health of the planet.

Here are several notable quotes from the 3 interviews on the topic of climate change and its effects regarding allergic conditions.

On Pollution and Its Impact on Climate Change

What's pretty clear is that manmade air pollution is a singular driver to the changing climate that we're seeing now. The carbon footprint is essential and it becomes a cycle. What happens is that as you have man-made pollutants, you change climate, you have you have a warmer climate, and that changes the likelihood that pollutants are going to be produced, then you're going to get more pollutants, that then changes the climate, so it becomes a little bit of a cycle…Fossil fuel, combustion, is clearly the most significant driver of climate change that we have.

There's really two prongs to it. When we combust fossil fuels, it both releases the greenhouse gasses that accelerate climate change and global warming. Then there's the direct effect from all of those pollutants, those things that we breathe in, that we eat, and that we consume. All of those have impacts on our health and wellbeing.

The (Environmental Protection Agency) has designated 188 hazardous air pollutants, and these are known bad actors. These are things like acrolein, benzene, cadmium, mercury, and we know that these are not good for our health. Then there's the criteria air pollutants and those are 6 things that affect more broader air quality. Those are things like particulate matter, 2.5, or PM2.5. Things like ozone, oxides of nitrogen, sulfur dioxide, but it also encompasses lead and carbon monoxide.

Right now, there are efforts to try and address what's happening in regard to fossil fuel emissions and efforts in regard to public health, but very little at the governmental level. I think if you looked at all of the money that the National Institute of Health spent in the last 3 years on average each year, they're spending about $12 million. That's a million, not a billion. So these issues related to the climate and health are obviously important, and pollen is just one aspect of that. But you can look at air quality, you can look at heat stress. There's so many more aspects of this that we just don't really have a full grasp on yet. I think there's a lot more that we need to know.

Cerceo, Peden, and Ziska joined HCPLive to speak on the imminent threat posed by climate change, highlighting the impact especially on individuals with allergic disease.

A Rising Tide: The Impact of Climate Change on Allergic Disease

Seasonal Allergy

Latest News